PRESS RELEASE published on 08/05/2025 at 16:25, 1 year 1 month ago Form 8.3 - The Vanguard Group, Inc.: QUALCOMM Inc The Vanguard Group, Inc. discloses a 10.65% ownership in QUALCOMM Inc. through 114,906,345 relevant securities. Details in Form 8.3 submission Form 8.3 Relevant Securities Vanguard Group Ownership Disclosure Qualcomm Inc.
PRESS RELEASE published on 08/05/2025 at 16:24, 1 year 1 month ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings Inc The Vanguard Group discloses a 7.63% stake in American Axle & Manufacturing Holdings. Details in Form 8.3 filing on 05-Aug-2025 Form 8.3 The Vanguard Group Financial Filing Stake Disclosure American Axle & Manufacturing Holdings
BRIEF published on 08/05/2025 at 16:21, 1 year 1 month ago The Vanguard Group Discloses Stake in Unite Group plc Takeover Code Vanguard Group Shareholding Market Disclosure Unite Group
PRESS RELEASE published on 08/05/2025 at 16:16, 1 year 1 month ago Form 8.3 - The Vanguard Group, Inc.: Unite Group plc, The The Vanguard Group, Inc. discloses 4.55% stake in Unite Group plc. Form 8.3 filing under the Takeover Code Form 8.3 Takeover Code The Vanguard Group Inc. Stake Disclosure Unite Group Plc
BRIEF published on 08/04/2025 at 16:49, 1 year 1 month ago Vanguard Group Discloses Position in Mural Oncology plc Securities Form 8.3 Irish Takeover Panel Vanguard Group Mural Oncology
BRIEF published on 08/04/2025 at 16:47, 1 year 1 month ago The Vanguard Group Discloses Stake in Dalata Hotel Group Form 8.3 Irish Takeover Panel Securities Disclosure Vanguard Group Dalata Hotel Group
BRIEF published on 08/04/2025 at 16:45, 1 year 1 month ago The Vanguard Group Discloses Position in Unite Group plc Securities Form 8.3 Takeover Code Vanguard Unite Group
PRESS RELEASE published on 08/04/2025 at 16:44, 1 year 1 month ago Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc The Vanguard Group, Inc. discloses an opening position in Mural Oncology plc. Details of relevant securities holdings and short positions revealed Short Positions Vanguard Group Securities Holdings Opening Position Mural Oncology Plc
BRIEF published on 08/04/2025 at 16:43, 1 year 1 month ago The Vanguard Group Discloses Position in Tritax Big Box REIT plc Form 8.3 Takeover Code Vanguard Group Shareholding Disclosure Tritax Big Box REIT
BRIEF published on 08/04/2025 at 16:42, 1 year 1 month ago The Vanguard Group Discloses Stake in Spirent Communications Form 8.3 Takeover Code Stake Disclosure Vanguard Spirent Communications
Published on 09/12/2026 at 02:35, 17 hours 16 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 20 hours 51 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 21 hours 46 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 22 hours 26 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 1 day 2 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 17:50, 2 hours 1 minute ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 12 hours 21 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 21 hours 36 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 21 hours 41 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 1 day ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 07:00, 1 day 12 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
